97. Ulcerative colitis
2,269 clinical trials,   1,331 drugs   (DrugBank: 241 drugs),   114 drug target genes,   181 drug target pathways

Searched query = "Ulcerative colitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00309660
(ClinicalTrials.gov)
November 200530/3/2006Treatment With Local PPARgamma Ligand in Distal Ulcerative ColitisUlcerative ColitisDrug: RosiglitazoneHerlev HospitalNULLRecruiting18 Years80 YearsBoth20Phase 1;Phase 2Denmark
2NCT00065065
(ClinicalTrials.gov)
September 200216/7/2003A Trial of Rosiglitazone for Ulcerative ColitisA Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative ColitisUlcerative Colitis;Inflammatory Bowel DiseaseDrug: Rosiglitazone;Drug: PlaceboJames LewisNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);GlaxoSmithKlineCompleted18 YearsN/AAll105Phase 2United States